Meet the Startup Innovators Fueling the Future for Cancer Treatment
Some of tomorrow’s biggest breakthroughs in cancer treatment are in the works today in startup labs across the US. On March 30th 2022, Genome Startup Day brought together CEOs and leaders in the cancer startup industry for a behind-the-scenes look at how emerging technologies are taking aim at one of the deadliest diseases in our world, and how these startup leaders are carving successful careers in the cancer tech landscape.
We were honored to welcome Dr. Greg Evans, National Cancer Institute Program Director and Team Leader, for a fireside chat with Phase Genomics CEO and Co-Founder Dr. Ivan Liachko. Their insights shed light on the funding process behind emerging technologies and how to start on the road to success.